ArticleBMB reports2017

Neuropeptide Y improves cisplatin-induced bone marrow dysfunction without blocking chemotherapeutic efficacy in a cancer mouse model.

Min Hee Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.